Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001449081 | SCV001652186 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-06-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456759 | SCV002615582 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-12 | criteria provided, single submitter | clinical testing | The c.1146T>G variant (also known as p.G382G), located in coding exon 11 of the PMS2 gene, results from a T to G substitution at nucleotide position 1146. This nucleotide substitution does not change the amino acid at codon 382. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive and direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699384 | SCV005203467 | uncertain significance | not specified | 2024-07-18 | criteria provided, single submitter | clinical testing |